May 8, 2020 / 12:34 PM / 22 days ago

BRIEF-FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

May 8 (Reuters) - Amgen Inc:

* FDA GRANTS FAST TRACK DESIGNATION FOR OMECAMTIV MECARBIL IN HEART FAILURE

* AMGEN - TOP-LINE RESULTS FROM GALACTIC-HF ARE EXPECTED IN Q4 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below